Applied BioCode signs distribution agreement with Henry Schein
Applied BioCode announced a distribution agreement with Henry Schein to expand availability of its BioCode MDx-3000 System and molecular diagnostics menu.
Applied BioCode said today it has signed a distribution agreement with Henry Schein, a healthcare products and services provider, to widen availability of its BioCode® MDx-3000 System and its molecular diagnostics menu. The BioCode® MDx-3000 is an automated, high-throughput multiple…